id | C00020217 |
---|---|
Name | Pratol / 7-Hydroxy-4'-methoxyflavone |
CAS RN | 487-24-1 |
Standard InChI | InChI=1S/C16H12O4/c1-19-12-5-2-10(3-6-12)15-9-14(18)13-7-4-11(17)8-16(13)20-15/h2-9,17H,1H3 |
Standard InChI (Main Layer) | InChI=1S/C16H12O4/c1-19-12-5-2-10(3-6-12)15-9-14(18)13-7-4-11(17)8-16(13)20-15/h2-9,17H,1H3 |
Phytochemical cluster | No. 15 |
---|---|
KCF-S cluster | No. 76 |
By standard InChI | CHEMBL16751 |
---|---|
By standard InChI Main Layer | CHEMBL16751 |
By LinkDB |
---|
By CAS RN |
---|
KNApSAcK organism | *ID | *family | *plant class | *kingdom |
---|---|---|---|---|
Bauhinia guianensis | 508984 | Fabaceae | rosids | Viridiplantae |
Caragana microphylla | 220690 | Fabaceae | rosids | Viridiplantae |
Trifolium pratense | 57577 | Fabaceae | rosids | Viridiplantae |
accession | description | class description | compound | assay ID (# of activities) |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|---|
P04637 | Cellular tumor antigen p53 | Transcription Factor | CHEMBL16751 |
CHEMBL1613992
(1)
CHEMBL1613995
(1)
|
7 / 44 |
Q13526 | Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | Enzyme | CHEMBL16751 |
CHEMBL1794585
(1)
|
0 / 0 |
O95271 | Tankyrase-1 | Enzyme | CHEMBL16751 |
CHEMBL2341188
(2)
|
0 / 0 |
P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | CHEMBL16751 |
CHEMBL1614027
(1)
|
0 / 1 |
P17405 | Sphingomyelin phosphodiesterase | Enzyme | CHEMBL16751 |
CHEMBL1794495
(1)
|
2 / 2 |
P38398 | Breast cancer type 1 susceptibility protein | Enzyme | CHEMBL16751 |
CHEMBL2114807
(1)
|
4 / 2 |
P09874 | Poly [ADP-ribose] polymerase 1 | Enzyme | CHEMBL16751 |
CHEMBL2341185
(1)
|
0 / 0 |
P63092 | Guanine nucleotide-binding protein G(s) subunit alpha isoforms short | Other membrane protein | CHEMBL16751 |
CHEMBL2114810
(1)
|
7 / 3 |
P11308 | Transcriptional regulator ERG | Unclassified protein | CHEMBL16751 |
CHEMBL2114924
(1)
|
1 / 2 |
P11021 | 78 kDa glucose-regulated protein | Unclassified protein | CHEMBL16751 |
CHEMBL1963893
(1)
|
0 / 0 |
Q9H2K2 | Tankyrase-2 | Enzyme | CHEMBL16751 |
CHEMBL2341186
(2)
|
0 / 0 |
P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | CHEMBL16751 |
CHEMBL1613777
(1)
|
1 / 1 |
P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | CHEMBL16751 |
CHEMBL1614108
(1)
CHEMBL1613886
(1)
|
0 / 1 |
Q9UBT6 | DNA polymerase kappa | Enzyme | CHEMBL16751 |
CHEMBL1794536
(1)
|
0 / 0 |
O00255 | Menin | Unclassified protein | CHEMBL16751 |
CHEMBL1614257
(1)
|
2 / 5 |
Q03164 | Histone-lysine N-methyltransferase 2A | Enzyme | CHEMBL16751 |
CHEMBL1614257
(1)
|
1 / 3 |
OMIM | preferred title | UniProt |
---|---|---|
#219080 | Acth-independent macronodular adrenal hyperplasia; aimah |
P63092
|
#202300 | Adrenocortical carcinoma, hereditary; adcc |
P04637
|
#614740 | Basal cell carcinoma, susceptibility to, 7; bcc7 |
P04637
|
#114480 | Breast cancer |
P38398
|
#604370 | Breast-ovarian cancer, familial, susceptibility to, 1; brovca1 |
P38398
|
#609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
#133239 | Esophageal cancer |
P04637
|
#612219 | Ewing sarcoma; es |
P11308
|
#605130 | Hairy elbows, short stature, facial dysmorphism, and developmental delay |
Q03164
|
#145000 | Hyperparathyroidism 1; hrpt1 |
O00255
|
#151623 | Li-fraumeni syndrome 1; lfs1 |
P04637
|
#211980 | Lung cancer |
P04637
|
#174800 | Mccune-albright syndrome; mas |
P63092
|
#131100 | Multiple endocrine neoplasia, type i; men1 |
O00255
|
#257200 | Niemann-pick disease, type a |
P17405
|
#607616 | Niemann-pick disease, type b |
P17405
|
#166350 | Osseous heteroplasia, progressive; poh |
P63092
|
#167000 | Ovarian cancer |
P38398
|
#614320 | Pancreatic cancer, susceptibility to, 4; pnca4 |
P38398
|
#260500 | Papilloma of choroid plexus; cpp |
P04637
|
#102200 | Pituitary adenoma, growth hormone-secreting |
P63092
|
#103580 | Pseudohypoparathyroidism, type ia; php1a |
P63092
|
#603233 | Pseudohypoparathyroidism, type ib; php1b |
P63092
|
#612462 | Pseudohypoparathyroidism, type ic; php1c |
P63092
|
#275355 | Squamous cell carcinoma, head and neck; hnscc |
P04637
|
KEGG | disease name | UniProt |
---|---|---|
H00033 | Adrenal carcinoma |
O00255
(related)
P04637 (related) |
H00034 | Carcinoid |
O00255
(related)
|
H00045 | Malignant islet cell carcinoma |
O00255
(related)
|
H00246 | Primary hyperparathyroidism |
O00255
(related)
|
H01102 | Pituitary adenomas |
O00255
(related)
|
H00004 | Chronic myeloid leukemia (CML) |
P04637
(related)
|
H00005 | Chronic lymphocytic leukemia (CLL) |
P04637
(related)
|
H00006 | Hairy-cell leukemia |
P04637
(related)
|
H00008 | Burkitt lymphoma |
P04637
(related)
|
H00009 | Adult T-cell leukemia |
P04637
(related)
|
H00010 | Multiple myeloma |
P04637
(related)
|
H00013 | Small cell lung cancer |
P04637
(related)
|
H00014 | Non-small cell lung cancer |
P04637
(related)
|
H00015 | Malignant pleural mesothelioma |
P04637
(related)
|
H00016 | Oral cancer |
P04637
(related)
P04637 (marker) |
H00017 | Esophageal cancer |
P04637
(related)
P04637 (marker) |
H00018 | Gastric cancer |
P04637
(related)
|
H00019 | Pancreatic cancer |
P04637
(related)
P04637 (marker) |
H00020 | Colorectal cancer |
P04637
(related)
P04637 (marker) |
H00022 | Bladder cancer |
P04637
(related)
|
H00025 | Penile cancer |
P04637
(related)
P04637 (marker) |
H00026 | Endometrial Cancer |
P04637
(related)
|
H00027 | Ovarian cancer |
P04637
(related)
P38398 (related) |
H00028 | Choriocarcinoma |
P04637
(related)
|
H00029 | Vulvar cancer |
P04637
(related)
|
H00031 | Breast cancer |
P04637
(related)
P38398 (related) |
H00032 | Thyroid cancer |
P04637
(related)
|
H00036 | Osteosarcoma |
P04637
(related)
P08684 (marker) |
H00038 | Malignant melanoma |
P04637
(related)
|
H00039 | Basal cell carcinoma |
P04637
(related)
|
H00040 | Squamous cell carcinoma |
P04637
(related)
|
H00041 | Kaposi's sarcoma |
P04637
(related)
|
H00042 | Glioma |
P04637
(related)
P04637 (marker) |
H00044 | Cancer of the anal canal |
P04637
(related)
|
H00046 | Cholangiocarcinoma |
P04637
(related)
|
H00047 | Gallbladder cancer |
P04637
(related)
|
H00048 | Hepatocellular carcinoma |
P04637
(related)
|
H00055 | Laryngeal cancer |
P04637
(related)
P04637 (marker) |
H00881 | Li-Fraumeni syndrome |
P04637
(related)
|
H01007 | Choroid plexus papilloma |
P04637
(related)
|
H00021 | Renal cell carcinoma |
P04637
(marker)
|
H00024 | Prostate cancer |
P11308
(related)
|
H00035 | Ewing's sarcoma |
P11308
(related)
|
H01205 | Coumarin resistance |
P11712
(related)
|
H00137 | Niemann-Pick disease (NPD) typeA and B |
P17405
(related)
|
H00424 | Defects in the degradation of sphingomyelin |
P17405
(related)
|
H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
H00244 | Pseudohypoparathyroidism |
P63092
(related)
|
H00441 | Progressive osseous heteroplasia (POH) |
P63092
(related)
|
H00501 | Fibrous dysplasia, polyostotic |
P63092
(related)
|
H00001 | Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia) |
Q03164
(related)
Q03164 (marker) |
H00002 | Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia) |
Q03164
(related)
|